mesalamine has been researched along with Diabetes Mellitus in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, Z | 1 |
| Zhu, B | 1 |
| Jin, X | 1 |
1 other study available for mesalamine and Diabetes Mellitus
| Article | Year |
|---|---|
Onset of HLA-B27-associated diseases in diabetic patient during a period of religious fasting: A case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diabetes Mellitus; Diagnostic Techniqu | 2018 |